Literature DB >> 33741566

What do we know about lateral flow tests and mass testing in schools?

Ingrid Torjesen1.   

Abstract

Year:  2021        PMID： 33741566     DOI： 10.1136/bmj.n706

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Rapid antigen testing in COVID-19 management for school-aged children: an observational study in Cheshire and Merseyside, UK.

Authors:  David M Hughes; Sheila M Bird; Christopher P Cheyne; Matthew Ashton; Melisa C Campbell; Marta García-Fiñana; Iain Buchan
Journal:  J Public Health (Oxf)       Date:  2022-02-04       Impact factor: 2.341

2.  Exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: survey and qualitative research.

Authors:  Jonathan Mathers; Christopher Poyner; Dean Thompson; Gavin Rudge; Ruth V Pritchett
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006

3.  Testing for COVID-19 during an outbreak within a large UK prison: an evaluation of mass testing to inform outbreak control.

Authors:  Claire Blackmore; Maciej Czachorowski; Elizabeth Farrington; Éamonn O'Moore; Emma Plugge
Journal:  Int J Infect Dis       Date:  2022-10-17       Impact factor: 12.074

4.  Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis study.

Authors:  Mark Drakesmith; Brendan Collins; Angela Jones; Kelechi Nnoaham; Daniel Rhys Thomas
Journal:  BMC Health Serv Res       Date:  2022-09-22       Impact factor: 2.908

5.  Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis.

Authors:  Naomi Fujita-Rohwerder; Lars Beckmann; Yvonne Zens; Arpana Verma
Journal:  BMJ Evid Based Med       Date:  2022-01-18

6.  When intuition falters: repeated testing accuracy during an epidemic.

Authors:  James A Hay; Joel Hellewell; Xueting Qiu
Journal:  Eur J Epidemiol       Date:  2021-07-28       Impact factor: 8.082
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.